An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom

An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom

Mostra altre versioni (1)

Background: Adjuvant! Online is an internet-based computer programme providing 10-year prognosis predictions for early breast cancer patients. It was developed in the United States, has been successfully validated in Canada, and is used in the United Kingdom and elsewhere. This study investigates th...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Campbell, H, Taylor, M, Harris, A, Gray, A
Altri autori:	Cancer Research UK
Natura:	Journal article
Lingua:	English
Pubblicazione:	Nature Publishing Group 2009
Soggetti:	Public Health Oncology

Documenti analoghi

An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.
di: Campbell, H, et al.
Pubblicazione: (2009)

Peripheral T-cell lymphoma in childhood: population-based experience in the United Kingdom over 20 years
di: Windsor, R, et al.
Pubblicazione: (2008)

Adjuvant and Neoadjuvant Therapy for Breast Cancer: A Systematic Review
di: Amal Sayfuldeen Qari, et al.
Pubblicazione: (2024-07-01)

Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trial
di: Mark Opdam, et al.
Pubblicazione: (2024-08-01)

Predictive value of TCR Vβ-Jβ profile for adjuvant gefitinib in EGFR mutant NSCLC from ADJUVANT-CTONG 1104 trial
di: Cunte Chen, et al.
Pubblicazione: (2022-01-01)

ToPP: Tumor online prognostic analysis platform for prognostic feature selection and clinical patient subgroup selection
di: Jian Ouyang, et al.
Pubblicazione: (2022-05-01)

Recruiting Opinion Leaders for the United Kingdom ASSIST Programme
di: Holliday, J, et al.
Pubblicazione: (2017)

Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis
di: Knowles, H, et al.
Pubblicazione: (2001)

Tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma
di: Dongjiang Chen, et al.
Pubblicazione: (2022-04-01)

Fatal case of sorafenib-associated idiosyncratic hepatotoxicity in the adjuvant treatment of a patient with renal cell carcinoma.
di: Fairfax, B, et al.
Pubblicazione: (2012)

The adherence and tolerance of adjuvant endocrine therapy in geriatric breast cancer patients
di: Meng-Ting Peng, et al.
Pubblicazione: (2016-09-01)

Adherence status to Adjuvant Endocrine Therapy in Chinese Women with Early Breast Cancer and its influencing factors: A cross‐sectional survey
di: Hui Xu, et al.
Pubblicazione: (2020-06-01)

Cardiovascular events and venous thromboembolism after primary malignant or non-malignant brain tumour diagnosis: a population matched cohort study in Wales (United Kingdom)
di: Michael T. C. Poon, et al.
Pubblicazione: (2023-11-01)

Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer
di: Eoin P. Kerin, et al.
Pubblicazione: (2022-12-01)

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
di: Williams, C, et al.
Pubblicazione: (2006)

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy
di: C Williams, et al.
Pubblicazione: (2006-09-01)

Effectiveness of adjuvant chemotherapy for elderly patients with triple-negative breast cancer
di: Qiusheng Guo, et al.
Pubblicazione: (2023-05-01)

Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK.
di: Campbell, H, et al.
Pubblicazione: (2010)

Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications
di: Agata Bikiewicz, et al.
Pubblicazione: (2021-08-01)

Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/neu in breast cancer and is an independent predictor of prognosis
di: Winters, Z, et al.
Pubblicazione: (2003)

The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom
di: Michele A. Kohli, et al.
Pubblicazione: (2021-11-01)

Adjuvant Therapy Reduces Fat Mass Loss during Exercise Prescription in Breast Cancer Survivors
di: Gabriele Mascherini, et al.
Pubblicazione: (2020-07-01)

Effects of yoga practice on physiological distress, fatigue and QOL in patients affected by breast cancer undergoing adjuvant radiotherapy
di: Simona Micheletti, et al.
Pubblicazione: (2022-12-01)

The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer
di: Michalina Janiszewska, et al.
Pubblicazione: (2021-06-01)

Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer
di: Elizabeth Comen, et al.
Pubblicazione: (2024-02-01)

Effect of metformin on breast cancer metabolism
di: Lord, S, et al.
Pubblicazione: (2014)

Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer
di: Sagar Sardesai, et al.
Pubblicazione: (2020-11-01)

Women’s Beliefs on Early Adherence to Adjuvant Endocrine Therapy for Breast Cancer: A Theory-Based Qualitative Study to Guide the Development of Community Pharmacist Interventions
di: Brittany Humphries, et al.
Pubblicazione: (2018-06-01)

Patient Preferences for Treatment in Relapsed/Refractory Acute Leukemia in the United Kingdom: A Discrete Choice Experiment
di: Mott DJ, et al.
Pubblicazione: (2024-06-01)

Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare.
di: Griffiths, R, et al.
Pubblicazione: (2012)

Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer
di: He Huang, et al.
Pubblicazione: (2022-08-01)

Adaptation to chronic hypoxia in triple-negative breast cancer
di: Hartley, F
Pubblicazione: (2023)

DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
di: Thale Kristin Olsen, et al.
Pubblicazione: (2022-10-01)

APAVAC Immunotherapy for the Adjuvant Treatment of a Canine Mucosal Melanoma
di: Valentina Rinaldi, et al.
Pubblicazione: (2024-12-01)

EnROL: a multicentre randomised trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme.
di: Kennedy, R, et al.
Pubblicazione: (2012)

Prognostic fine needle aspiration biopsy of uveal melanoma: Molecular and genetic factors of metastasis risk
di: V. A. Yarovaya, et al.
Pubblicazione: (2023-10-01)

Breast cancer in young families: a qualitative interview study of fathers and their role and communication with their children following the diagnosis of maternal breast cancer
di: Forrest, G, et al.
Pubblicazione: (2009)

Herceptin resistance in HER2-moderately expressed breast cancer
di: Kerry, J, et al.
Pubblicazione: (2012)

Response and resistance to lapatinib in HER2-overexpressing breast cancer
di: Leung, W
Pubblicazione: (2014)

Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer
di: Caroline Muñoz, et al.
Pubblicazione: (2024-03-01)